Wytwarzanie beta-laktamaz o rozszerzonym spektrum substratowym (ESBL) przez bakterie występujące w żywności

• Autorzy: Wasinski B. , Rozanska H. , Osek J.

Warianty tytułu

EN

Production of extended spectrum beta-lactamases (ESBL) by bacteria present in food

• Języki publikacji: PL

Abstrakty

EN

Extended-spectrum beta-lactamases (ESBL) have recently been among the most frequent causes of antimicrobial resistance in bacterial strains from the family Enterobacteriaceae. Especially dangerous features of these enzymes are their diversity and ability to spread with plasmids among strains of the same bacterial species or between different species. ESBL-producing strains, found in the past mainly in nosocomial infections, now often cause community-acquired infections. The strains producing ESBL are also widespread among animals, which constitute reservoirs of these microbes and sources of infection in humans. An important path for transmission of these infections are most probably meat and meat products. This paper presents the current state of knowledge concerning the transmission of ESBL-producing Enterobacteriaceae from animals to humans via animal meat and meat products.

Słowa kluczowe

PL

zywnosc; zywnosc pochodzenia zwierzecego; mieso; produkty miesne; bakterie Gram-ujemne; beta-laktamaza o rozszerzonym spektrum substratowym; szczepy wytwarzajace ESBL; wystepowanie; epidemiologia

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2013
• Tom: 69
• Numer: 05
• Opis fizyczny: s.274-278,bibliogr.

Twórcy

autor

Wasinski B.

• Zakład Higieny Żywności Pochodzenia Zwierzęcego, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, Al.Partyzantów 57, 24-100 Puławy

autor

Rozanska H.

• Zakład Higieny Żywności Pochodzenia Zwierzęcego, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, Al.Partyzantów 57, 24-100 Puławy

autor

Osek J.

• Zakład Higieny Żywności Pochodzenia Zwierzęcego, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, Al.Partyzantów 57, 24-100 Puławy

Bibliografia

• 1.Abraham E. P., Chain E.: An enzyme from bacteria able to destroy penicillin. Nature 1940, 146, 837.
• 2.Ambler R. P.: The structure of beta-lactamases. Philosoph. Trans. Royal Soc. of London B. 1980, 289, 321-331.
• 3.Baraniak A.: Epidemiologia molekularna i ewolucja szczepów Enterobacteriaceae wytwarzających β-laktamazy o rozszerzonym spektrum substratowym (ESBL) w Polsce. Praca dokt. Wydział Biologii, Uniwersytet Warszawski, Warszawa 2010.
• 4.Bradford P. A.: Extended-spectrum â-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 2001, 14, 933-951.
• 5.Bush K., Jackoby G. A.: Updated functional classification of beta-lactamases. Antimicrob. Agents Chemother. 2010, 54, 969-976.
• 6.Bush K., Jacoby G. A., Medeiros A. A.: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 1995, 39, 1211-1233.
• 7.Carattoli A.: Animal reservoirs for extended spectrum beta-lactamase producers. Clin. Microbiol. Infect. 2008, 14 (Suppl. 1), 117-123.
• 8.Coque T. M., Baquero T. M., Canton R.: Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance 2008, 13, no. 47.
• 9.Coque T. M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Canton R., Nordmann P.: Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 2008, 14, 195-200.
• 10.Derikx C. M., van Duijkeren E., Schoormans A. H., van Essen-Zandbergen A., Veldman K., Kant A., Huijsdens X. W., van der Zwaluw K., Wagenaar J. A., Mevius D. J.: Occurrence and characteristicks of extended-spectrum β-lactamase- and Amp C-producing clinical isolates derived from companion animals and horses. J. Antimicrob. Chemother. 2012, 67, 1368-1374.
• 11.Dzierżanowska D., Pawińska A., Kamisńka W., Patzer J.: Lekooporne drobnoustroje w zakażeniach szpitalnych. Post. Mikrobiol. 2004, 43, 81-105.
• 12.Essack F. Y., Hall M. L. C., Pillay D. G., McFadeyn M. L., Livermore D. M.: Complexity and diversity of Klebsiella pneumoniae strains with extended spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob. Agents Chemother. 2001, 45, 88-95.
• 13.European Food Safety Authority: Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum â-lactamases and/or Amp C β-lactamases in food and food-producing animals. EFSA Journal 2011, 9, 2322.
• 14.Ewers C., Bethe A., Semmeler T., Guenther S., Wieler L. H.: Extended spectrum β-lactamase-producing and Amp C-producing Escherichia coli from livestock and companion animals and their putative impact on public health a global perspective. Clin. Microbiol. Infect. 2012, 18, 646-655.
• 15.Falagas M. E., Karageorgopulos D. E.: Extended spectrum β-lactamase-producing organisms. J. Hospit. Infect. 2009, 73, 345-354.
• 16.Geser N., Stephan R., Hächler H.: Occurrence and characteristics of extended spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk. BMC Vet. Res. 2012, 8, 21.
• 17.Gniadkowski M.: Ewolucja i epidemiologia szczepów pałeczek z rodziny Enterobacteriaceae wytwarzających β-laktamazy o rozszerzonym spektrum substratowym (ESâL) w Polsce. Praca hab. Akademia Medyczna, Warszawa 2003.
• 18.Guenther S., Ewers C., Wieler L. H.: Extended-spectrum beta-lactamases producing in wildlife: yet another form of environmental polliution? Front. Microbiol. 2011, 2, 246.
• 19.Havkey P. M.: Prevalence and clonality of extended spectrum β-lactamases in Asia. Clin. Microbiol. Infect. 2008, 14, 159-165.
• 20.Hächler H.: Antibiotic resistence emerging along the food chain, for example MRSA and ESBL. Proc. Max Rubner Conference October 8-12, 2012, Karlsruhe, Germany, s. 19.
• 21.Khalaf N. G., Eletreby M. M., Hanson N. D.: Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect. Dis. 2009, 9, 84.
• 22.Kleibe C., Nies B. A., Meyer J. F.: Evaluation of plasmid-closed resistence to broad spectrum cephalosporins. Antimicrob. Agents Chemother. 1985, 28, 302-307.
• 23.Knothe H., Shah P., Kremery V., Antal M., Mitsuhashi S.: Transformable resistence to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983, 11, 315-317.
• 24.Leverstein-van Hall M. A., Dierikx C. M., Cohen Stuart J., Voets G. M., van den Munckhof M. P., van Essen-Zandbergen A., Platteel T., Fluit A. C., van de Sande-Bruiksma N., Scharinga J., Bonten M. J. M., Mevius D. J.: Dutch patients, retail chickem meat and poultry share the same ESBL genes, plasmids and strains. Clin. Microbiol. Infect. 2011, 17, 873-880.
• 25.Livermore D. M.: Defining an extended-spectrum β-lactamase. Clin. Microbiol. Infect. 2008, 14 Suppl. 1, 3-10.
• 26.Markiewicz Z., Kwiatkowski Z. A.: Bakterie antybiotyki lekooporność. Wydawnictwo Naukowe PWN, Warszawa 2001, s. 163 i 165.
• 27.Melano R. G., Davidson H. L., Musgrave H. L., Forward K. R.: Cephalosporin resistence in Klebsiella pneumoniae from Nova Scotia, Canada. Diagn. Microbiol. Infect. Dis. 2006, 56, 197-205.
• 28.Mora A., Herrera A., Mamani R., Lopez C., Alonso M. P., Blanco J. E., Blanco M., Dahbi G., Garcia-Garrote F., Pita J. M., Coira A., Bernardez M. I., Blanco J.: Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl. Environ. Microbiol. 2010, 76, 6991-6997.
• 29.Naas T., Bogaerts P., Bauraing C., Drgheldre Y., Glupczynski Y., Nordmann P.: Emergence of PER and VEB extended-spectrum â-lactamases in Acinetobacter baumannii in Belgium. J. Antimicrob. Chemother. 2006, 58, 178-182.
• 30.Ojer-Usoz E., González D., Vitas A. I., Leiva J., García-Jalón I., Febles-Casquero A., de la Soledad Escolano M.: Prevalence of extended spectrum β-lactamase-producing Enterobacteriaceae in meat products sold in Navarra, Spain. Meat Sci. 2013, 93, 316-321.
• 31.Paterson D. L., Bonomo R. A.: Extended spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 2005, 18, 657-686.
• 32.Petit A.: Molecular epidemiology of TEM-3 (CTX-M-1) β-lactamase. Antimicrob. Agents Cemother. 1990, 34, 219-224.
• 33.Pitout D. D., Nordmann P., Laupland K. B., Poiler L.: Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 2005, 56, 52-59.
• 34.Pitout J. D. D., Laupland K. B.: Extended spectrum β-lactamase producing Enterobacteriaceae: an emerging public-health problem. Lancet Infect. Dis. 2008, 8, 159-166.
• 35.Poirel L., Naas T., Guibert M., Chaibi E. T., Labia R., Nordmann P.: Molecular and biochemical characterization of Veb-1, a novel class A extended spectrum beta-lactamase encoded by an Escherichia coli integrin gene. Antimicrob. Agents Chemother. 1999, 43, 573-581.
• 36.Rish H., Dhillon P., Clark J.: ESBL-s: A clear and present danger? Crit. Care Res. Pract. 2012, 625170, 1-11.
• 37.Rzewuska M.: Antybiotykooporność Gram-ujemnych pałeczek wytwarzających beta-laktamazy. Życie Wet. 2009, 84, 199-205.
• 38.Tham J., Walder M., Melandr E., Odenholt I.: Prevalence of extended-spectrum beta-lactamase-producing bacteria in food. Infect. Drug Resist. 2012, 5, 143-147.
• 39.Vincent C., Boerlin P., Daignault D., Dozois C. M., Dutil L., Galanakis C., Reid-Smith R. J., Tellier P. P., Tellis P. A., Ziebell K., Manges A. R.: Food reservoir for Escherichia coli causing urinary tract infections. Emerg. Infect. Dis. 2010, 16, 88-95.